Association of P2Y12 G52T genetic polymorphism with recurrent thromboembolic events in stroke and myocardial infarction patients on clopidogrel therapy: a prospective observational study. [PDF]
Baiju A +17 more
europepmc +1 more source
Clopidogrel vs. Aspirin in Double Antithrombotic Therapy for Patients on Oral Anticoagulation Undergoing Coronary Stenting. [PDF]
Pompei G +7 more
europepmc +1 more source
Personalized P2Y12 Inhibitor Treatment
Jurriën M. ten Berg, Paul W.A. Janssen
openaire +1 more source
Patterns of antithrombotic treatment after left atrial appendage occlusion. [PDF]
Liu X +5 more
europepmc +1 more source
P2Y12 Inhibitor–Based Monotherapy
Rahul Choudhary, Surender Deora
openaire +1 more source
Phytochemical Profiling, Antiplatelet Potential, and Cytotoxic Assessment of Thymelaea tartonraira Aerial Part Essential Oil: In Vitro and In Silico Studies. [PDF]
Soltani S +8 more
europepmc +1 more source
Early aspirin withdrawal versus dual antiplatelet therapy in high-risk patients after percutaneous coronary intervention: Meta-analysis of randomized trials. [PDF]
Navarese EP +12 more
europepmc +1 more source
The efficacy and safety of ticagrelor and prasugrel versus clopidogrel in post-PCI dual antiplatelet therapy in chronic coronary syndrome: a systematic review and meta-analysis. [PDF]
Mirhosseini SA +12 more
europepmc +1 more source
Therapeutic Window of P2Y12 Inhibition
Iñigo Lozano +4 more
openaire +1 more source
2025 Acute Coronary Syndrome Guideline: Missing the Boat on <i>CYP2C19</i> Genotyping. [PDF]
Cavallari LH +9 more
europepmc +1 more source

